Long-term study of early esophageal cancer after endoscopic surgery
Part of Cancer, Digestive system clinical trials.
This study follows people who had early-stage esophageal cancer removed with a minimally invasive procedure (ESD) to see how they do over time. It aims to understand how often the cancer comes back or spreads, and what factors might affect that.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You had early-stage esophageal cancer (called squamous cell carcinoma) that was removed with an endoscopic procedure (ESD) and it was limited to the surface layers.
- The pathology report after ESD showed the cancer was at stage pT1a or pT1b.
- You have been followed for at least 3 years after the ESD, or you had a recurrence or lymph node spread during that follow-up.
- You did not have chemotherapy, radiation, or surgery for esophageal cancer before the ESD.
- You do not have any other current or past cancers (except early esophageal cancer) or tumors in the stomach or duodenum.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining radiation and chemotherapy after endoscopic removal of early-stage esophageal cancer can effectively treat the cancer without needing surgery. It may be an option for people whose cancer was removed with ESD but who want to avoid additional surgery.
This study looks at early stomach cancer treated with ESD, a procedure to remove the tumor through the stomach lining, and how the depth of the scar relates to healing. It may help doctors predict better outcomes and improve the procedure for suitable patients.
This study looks back at past patients’ medical and pathology records from esophageal cancer surgeries. It may help improve how doctors understand which advanced tumors should be treated, by reviewing outcomes in specific tumor stages.
This trial tests if adding radiation therapy after endoscopic surgery (ESD) helps people with early-stage esophageal cancer that had certain high-risk features, like deeper invasion or positive margins. It aims to improve outcomes for those who didn't get a complete cure with surgery alone.
This study follows people whose early esophageal adenocarcinoma was found during an endoscopy (ER) sample. The goal is to better understand what follow-up tests are needed based on higher-risk features and to watch for spread or incomplete removal.
This trial is checking outcomes for adults who are scheduled to have a procedure called endoscopic submucosal dissection (ESD), done through an endoscope. If you’re already planned for ESD and have no reasons you can’t have endoscopy, you may be able to join.
Hear when a new Early Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.